Genetic Technologies' Q3 Revenues Narrow 9 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies said after the close of the market on Tuesday that receipts from customers in its fiscal third quarter decreased 9 percent year over year.

For the three months ended March 31, the Australian company brought in A$1.2 million (US$1.2 million) in customer receipts, down from A$1.1 million a year ago, GTG said in a document filed with regulators in Australia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.